Renalytix has announced the pricing of its global offering raising $74.3m gross proceeds and shares will begin trading today on Nasdaq under the ticker “RNLX”. In aggregate, Renalytix will issue 11m new ordinary shares, representing 15.6% of enlarged share capital. The global offering was oversubscribed and highlights the strong institutional support for Renalytix and its leading KidneyIntelX platform as a prognostic tool for rapid progressing kidney function decline. The proceeds evolves the co ....
17 Jul 2020
Global offering to raise $74.3m, Nasdaq trading begins
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Global offering to raise $74.3m, Nasdaq trading begins
Renalytix Plc (RENX:LON) | 30.0 0 0.0% | Mkt Cap: 37.9m
- Published:
17 Jul 2020 -
Author:
Edward Thomason -
Pages:
3
Renalytix has announced the pricing of its global offering raising $74.3m gross proceeds and shares will begin trading today on Nasdaq under the ticker “RNLX”. In aggregate, Renalytix will issue 11m new ordinary shares, representing 15.6% of enlarged share capital. The global offering was oversubscribed and highlights the strong institutional support for Renalytix and its leading KidneyIntelX platform as a prognostic tool for rapid progressing kidney function decline. The proceeds evolves the co ....